Lycera initiates phase2 trial of LYC-30937-EC for psoriasis

[jiml]

It's good to see that Lycera are looking at the disease from a different angle, I hope that this oral drug will be successful as it will give dermatologists another weapon in their arsenal to attack this disease

I look forward to seeing the result of this phase 2 trial although it is only on a small number of patients